Melinta Therapeutics Announces Termination of Merger Agreement and Tender Offer for Shares of Tetraphase
MORRISTOWN, N.J., June 24, 2020 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (“Melinta”), a commercial-stage antibiotics company, announced that on June 24, 2020, pursuant to the Agreement and...
Melinta Therapeutics Enters Into Agreement to Acquire Tetraphase Pharmaceuticals
Company Enters Growth Phase in Hospital Market with Support of Deerfield